HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin delivery by implanted pump. A chronic treatment for diabetes.

Abstract
In the eight years that have elapsed since the first implantation of an insulin pump in a human subject, insulin delivered by implantable pump has been shown to improve metabolic control while reducing total and LDL cholesterol, serum amyloid A, and serum anti-insulin antibody titres. Both single-rate and programmable insulin pumps are now being evaluated in human trials with generally favorable results. Current clinical trial results indicate that the problem of insulin aggregation in pumps that inhibited initiation and expansion of clinical trials for several years has now been largely solved. Patients with implantable pumps are generally well-satisfied with this form of therapy, would choose it again, and recommend it to friends and relatives. Though currently more costly than subcutaneous insulin injections, the convenience of implantable pump therapy and the potential for reduction of diabetic complications through improved metabolic control may make it the treatment of choice in the future.
AuthorsH Buchwald, T D Rohde, K Kernstine
JournalASAIO transactions (ASAIO Trans) 1989 Jan-Mar Vol. 35 Issue 1 Pg. 5-7 ISSN: 0889-7190 [Print] United States
PMID2659052 (Publication Type: Journal Article, Review)
Chemical References
  • Insulin
Topics
  • Animals
  • Child
  • Diabetes Mellitus, Type 1 (drug therapy)
  • Dogs
  • Humans
  • Infusion Pumps
  • Insulin (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: